CTOs on the Move

OneOncology

www.oneoncology.com

 
OneOncology is a partnership of independent community oncology practices committed to driving the future of cancer care delivery through a patient-centric, physician-driven, and technology-powered model to help improve the lives of everyone living with cancer. OneOncology empowers community oncology practices by supporting the entire continuum of care, including prevention and diagnosis, research and treatment, and long-term survivorship, palliative, and hospice care. Our technology is powered by the Flatiron suite of services to provide access to key clinical and operational data and the latest research via a cloud-based network. This comprehensive approach supports community oncologists` transition to value-based care and commitment ...
  • Number of Employees: 1K-5K
  • Annual Revenue: > $1 Billion

Executives

Name Title Contact Details
Ben L.
VP, IT Support Model Profile
David Stewart
Chief Information Officer Profile
Andy Corts
Chief Technology Officer Profile

Funding

OneOncology raised $200M on 09/12/2018

Similar Companies

Matrixx Initiatives Inc.

Matrixx Initiatives Inc. is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Scottsdale, AZ. To find more information about Matrixx Initiatives Inc., please visit www.matrixxinc.com

Health Products Express

Health Products Express is a Winthrop, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

MolecularMD

MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.  

MDX/MEDIREX SYSTEMS

MDX/MEDIREX SYSTEMS Inc. is a Toronto, ON-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Cvi Medical Liquidators-Tx

Cvi Medical Liquidators-Tx is a Dallas, TX-based company in the Healthcare, Pharmaceuticals, and Biotech sector.